Salesforce (CRM) remains a buy with a DCF valuation of $280, implying ~20% upside from the current market price of $233.
Source Post
Is it Safe to Buy Salesforce Stock Right Now? | CRM STock Analysis
Sep 25, 2026
Salesforce's management has reassured investors about accelerating revenue growth in the latter half of 2027 and beyond, reaffirming a $63 billion revenue target by 2030 and strong operating margins. Despite past concerns about AI's impact and a significant stock price drop, the company has integrated AI into its services, boosting average selling prices and improving operating margins. The stock, which fell below $150 in June, has recovered above $232, and the creator maintains a buy rating, citing a forward P/E near historical lows and a DCF valuation of $280 per share, implying ~20% upside.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
CRMbuy opened Sep 25, 2026
+1.04%